References
- ASHP Council on Professional AffairsASHP guidelines on preventing medication errors with antineoplastic agentsAm J Health Syst Pharm20025916481668 10.1093/ajhp/59.17.1648
- Umar RM, Apikoglu-Rabus S, Yumuk PFSignificance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patientsInt J Clin Pharm202042652661 10.1007/s11096-020-00992-8
- European Medicines Agency. Medication errors. 2018 [cited 2022 Dec 5]. https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/medication-errors
- Institute of Medicine (US) Committee on Quality of Health Care in America. To Err is Human: Building a Safer Health System. Kohn LT, Corrigan JM, Donaldson MS, editors. Washington (DC): National Academies Press (US); 2000 [cited 2022 Dec 5]. http://www.ncbi.nlm.nih.gov/books/NBK225182/
- Ministero della Salute. Raccomandazione per la prevenzione della morte, coma o grave danno derivati da errori in terapia farmacologica. 2008 [cited 2023 Jan 2]. https://www.salute.gov.it/imgs/C_17_pubblicazioni_675_allegato.pdf
- Billstein-Leber M, Carrillo CJD, Cassano AT, Moline K, Robertson JJASHP Guidelines on Preventing Medication Errors in HospitalsAm J Health Syst Pharm20187514931517 10.2146/ajhp170811
- Goedecke T, Ord K, Newbould V, Brosch S, Arlett PMedication Errors: New EU Good Practice Guide on Risk Minimisation and Error PreventionDrug Saf201639491500 10.1007/s40264-016-0410-4
- European Medicines Agency. Good practice guide on risk minimisation and prevention of medication errors. 2015. http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2015/11/WC500196981.pdf
- Grissinger MFailure mode and effects analysis can help guide error-prevention effortsPharmacol Ther2003288
- Spath PLUsing failure mode and effects analysis to improve patient safetyAORN J2003781537 10.1016/S0001-2092(06)61343-4
- Cohen MR, Senders J, Davis NMFailure mode and effects analysis: a novel approach to avoiding dangerous medication errors and accidentsHosp Pharm199429319330 1:STN:280:DyaK2c3jtVSrtw%3D%3D
- Ashley L, Armitage G, Neary M, Hollingsworth GA practical guide to failure mode and effects analysis in health care: making the most of the team and its meetingsJt Comm J Qual Patient Saf201036351358
- Redfern E, Brown R, Vincent CAImproving communication in the emergency departmentEmerg Med J200926658661 1:STN:280:DC%2BD1Mrntlejuw%3D%3D 10.1136/emj.2008.065623
- Burke HBImproving the safety and quality of cancer careCancer2017123549550 10.1002/cncr.30438
- McKenzie H, Hayes L, White K, Cox K, Fethney J, Boughton M, et al.Chemotherapy outpatients’ unplanned presentations to hospital: a retrospective studySupport Care Cancer201119963969 10.1007/s00520-010-0913-y
- Sandrik KOncology: who’s managing outpatient programsHospitals1990643237 1:STN:280:DyaK3c7ivV2msg%3D%3D
- Lubell A. Inpatient versus Outpatient Chemotherapy—Benefits, Risks, and Costs. Cancer Therapy Advisor. 2012 https://www.cancertherapyadvisor.com/home/cancer-topics/general-oncology/inpatient-versus-outpatient-chemotherapy-benefits-risks-and-costs/
- Phillips J, Beam S, Brinker A, Holquist C, Honig P, Lee LY, et al.Retrospective analysis of mortalities associated with medication errors2001587
- La Russa R, Ascani A, Monaco C, Polidori PPrevenzione degli errori di terapia in oncologiaBollettino - Società Italiana di Farmacia Ospedaliera200551107
- Leone R, Sottosanti L, Iorio ML, Santuccio C, Conforti A, Sabatini V, et al.Drug-related deathsDrug-Safety200831703713 10.2165/00002018-200831080-00007
- Santell JP, Protzel MM, Cousins DMedication errors in oncology practiceUS Pharmacist.200429489
- Ministero della Salute. Raccomandazione per la prevenzione degli errori in terapia con farmaci antineoplastici. https://www.salute.gov.it/imgs/C_17_pubblicazioni_1861_allegato.pdf
- Buja A, Manfredi M, De Luca G, Zampieri C, Zanovello S, Perkovic D, et al.Using failure mode, effect and criticality analysis to improve safety in the COVID Mass Vaccination CampaignVaccines (Basel)20219866 1:CAS:528:DC%2BB3MXitVGrsrnE 10.3390/vaccines9080866
- Boulé M, Lachapelle S, Collin-Lévesque L, Demers É, Nguyen C, Fournier-Tondreau M, et al.Failure mode, effect, and criticality analysis of the parenteral nutrition process in a Mother-Child Hospital: The AMELIORE StudyNutr Clin Pract201833656666 10.1002/ncp.10094
- Ashokkumar R, Srinivasamurthy S, Kelly J, Howard S, Parasuraman S, Uppugunduri Satyanarayana CRFrequency of chemotherapy medication errors: A systematic reviewJ Pharmacol Pharmacother2018986 10.4103/jpp.JPP_61_18
- Setareh S, Rabiei R, Mirzaei HR, Roshanpoor A, Shaabani MEffects of guideline-based computerized provider order entry systems on the chemotherapy order process: a systematic reviewActa Inform Med2022306168 10.5455/aim.2022.30.61-68
- Radley DC, Wasserman MR, Olsho LE, Shoemaker SJ, Spranca MD, Bradshaw BReduction in medication errors in hospitals due to adoption of computerized provider order entry systemsJ Am Med Inform Assoc201320470476 10.1136/amiajnl-2012-001241
- Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, et al.Incidence of adverse drug events and potential adverse drug events Implications for preventionADE Prevention Study Group. JAMA.19952742934 1:STN:280:DyaK2MzhtFemtw%3D%3D
- Légat L, Van Laere S, Nyssen M, Steurbaut S, Dupont AG, Cornu PClinical decision support systems for drug allergy checking: systematic reviewJ Med Internet Res201820 10.2196/jmir.8206
- Shekelle PGClinical practice guidelines: what’s next?JAMA Am Med Assoc2018320757758 10.1001/jama.2018.9660
- Rodziewicz TL, Houseman B, Hipskind JE. Medical Error Reduction and Prevention. StatPearls. Treasure Island (FL): StatPearls Publishing; 2022. http://www.ncbi.nlm.nih.gov/books/NBK499956/
- Schulmeister LPatient misidentification in oncology careClin J Oncol Nurs200812495498 10.1188/08.CJON.495-498
- Ferguson C, Hickman L, Macbean C, Jackson DThe wicked problem of patient misidentification: how could the technological revolution help address patient safety?J Clin Nurs20192823652368
- Dyer CIdentifying patients in outpatient clinics must be improved, says safety watchdogBr Med J20213731440 10.1136/bmj.n1440
- Cousins DH, Gerrett D, Warner BA review of medication incidents reported to the National Reporting and Learning System in England and Wales over 6 years (2005–2010)Br J Clin Pharmacol201274597604 10.1111/j.1365-2125.2011.04166.x
- Hall KK, Shoemaker-Hunt S, Hoffman L, Richard S, Gall E, Schoyer E, et al. Making Healthcare Safer III: A Critical Analysis of Existing and Emerging Patient Safety Practices. Rockville (MD): Agency for Healthcare Research and Quality (US); 2020. http://www.ncbi.nlm.nih.gov/books/NBK555526/
- Garrido M, Faus V, Lopez-Martin C, et al. GRP-175 Smart Infusion Pumps in Chemotherapy Administration | European Journal of Hospital Pharmacy. https://ejhp.bmj.com/content/20/Suppl_1/A63.1.short
- Carrington C, Stone L, Koczwara B, Searle C, Siderov J, Stevenson B, et al.The Clinical Oncological Society of Australia (COSA) guidelines for the safe prescribing, dispensing and administration of cancer chemotherapyAsia Pac J Clin Oncol20106220237 10.1111/j.1743-7563.2010.01321.x
- Provincial Pediatric Oncology Satellite Manual. https://www.pogo.ca/wp-content/uploads/2021/11/3.1.2-Preparation-Transport-and-Storage.pdf
- International Society of Oncology Pharmacy Practitioners Standards Committee. ISOPP standards of practice. Safe handling of cytotoxics. J Oncol Pharm Pract. 2007;13:1–81.
- Fey T, Erickson N, Stahler A, Muenchhoff M, Keppler OT, Ruehlmann K, et al.Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoVMed Oncol202239104 1:CAS:528:DC%2BB38XhtVGit77L 10.1007/s12032-022-01700-4